Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grana

Showing results (581-590 of 603) with videos related to

Pageof 61
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paragangliomaMarta Laganà, Mouhammed Amir Habra, Hanna Remde, et al.
Cancer Heterogeneity and Plasticity|July 13, 2026
YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasisJingjing Wu, Dipti Athavale, Curt Balch, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and MetastasesJingjing Wu, Dipti Athavale, Curt Balch, et al.
Frontiers in Genetics|July 6, 2019
The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment ApproachBriseida E Feliciano-Astacio, Katrina Celis, Jairo Ramos, et al.
Journal of Endocrinological Investigation|August 18, 2020
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)F Panzuto, M Maccauro, D Campana, et al.
Journal of Neuroendocrinology|November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and managementNicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Lancet (London, England)|July 2, 2026
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trialThomas Walter, Henning Jann, Catherine Ansquer, et al.
Medical Image Analysis|May 8, 2026
Multi-structure segmentation in CBCT volumes: The ToothFairy2 challengeFederico Bolelli, Luca Lumetti, Niels van Nistelrooij, et al.
Journal of the National Cancer Institute|March 1, 2018
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test ResultsAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Pageof 61

Showing results (581-590 of 603) with videos related to

Sort By:
Pageof 61
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paragangliomaMarta Laganà, Mouhammed Amir Habra, Hanna Remde, et al.
Cancer Heterogeneity and Plasticity|July 13, 2026
YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasisJingjing Wu, Dipti Athavale, Curt Balch, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and MetastasesJingjing Wu, Dipti Athavale, Curt Balch, et al.
Frontiers in Genetics|July 6, 2019
The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment ApproachBriseida E Feliciano-Astacio, Katrina Celis, Jairo Ramos, et al.
Journal of Endocrinological Investigation|August 18, 2020
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)F Panzuto, M Maccauro, D Campana, et al.
Journal of Neuroendocrinology|November 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and managementNicola Fazio, Patrick Maisonneuve, Anna Maria Frezza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Lancet (London, England)|July 2, 2026
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trialThomas Walter, Henning Jann, Catherine Ansquer, et al.
Medical Image Analysis|May 8, 2026
Multi-structure segmentation in CBCT volumes: The ToothFairy2 challengeFederico Bolelli, Luca Lumetti, Niels van Nistelrooij, et al.
Journal of the National Cancer Institute|March 1, 2018
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test ResultsAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Pageof 61